Cargando…
Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
Patient‐specific quality assurance for intensity‐modulated radiation therapy (IMRT) dose verification is essential. The aim of this study is to provide a new method based on the relative error distribution by comparing the fluence map from the treatment planning system (TPS) and the incident fluence...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690227/ https://www.ncbi.nlm.nih.gov/pubmed/26894363 http://dx.doi.org/10.1120/jacmp.v17i1.5899 |
_version_ | 1783279560049033216 |
---|---|
author | Sumida, Iori Yamaguchi, Hajime Das, Indra J. Kizaki, Hisao Aboshi, Keiko Tsujii, Mari Yamada, Yuji Suzuki, Osamu Seo, Yuji Isohashi, Fumiaki Ogawa, Kazuhiko |
author_facet | Sumida, Iori Yamaguchi, Hajime Das, Indra J. Kizaki, Hisao Aboshi, Keiko Tsujii, Mari Yamada, Yuji Suzuki, Osamu Seo, Yuji Isohashi, Fumiaki Ogawa, Kazuhiko |
author_sort | Sumida, Iori |
collection | PubMed |
description | Patient‐specific quality assurance for intensity‐modulated radiation therapy (IMRT) dose verification is essential. The aim of this study is to provide a new method based on the relative error distribution by comparing the fluence map from the treatment planning system (TPS) and the incident fluence deconvolved from the electronic portal imaging device (EPID) images. This method is validated for 10 head and neck IMRT cases. The fluence map of each beam was exported from the TPS and EPID images of the treatment beams were acquired. Measured EPID images were deconvolved to the incident fluence with proper corrections. The relative error distribution between the TPS fluence map and the incident fluence from the EPID was created. This was also created for a 2D diode array detector. The absolute point dose was measured with an ionization chamber, and the dose distribution was measured by a radiochromic film. In three cases, MLC leaf positions were intentionally changed to create the dose error as much as 5% against the planned dose and our fluence‐based method was tested using gamma index. Absolute errors between the predicted dose of 2D diode detector and of our method and measurements were [Formula: see text] and [Formula: see text] respectively. The gamma passing rate (3% global / 3 mm) of the TPS was higher than that of the 2D diode detector ([Formula: see text]), and lower than that of the EPID ([Formula: see text]). The gamma passing rate (2% global / 2 mm) of the TPS was higher than that of the 2D diode detector, while the gamma passing rate of the TPS was lower than that of EPID ([Formula: see text]). For three modified plans, the predicted dose errors against the measured dose were 1.10%, 2.14%, and [Formula: see text]. The predicted dose distributions from the EPID were well matched to the measurements. Our fluence‐based method provides very accurate dosimetry for IMRT patients. The method is simple and can be adapted to any clinic for complex cases. PACS numbers: 87.55.D‐, 87.55.km, 87.55.Qr, 87.57.uq |
format | Online Article Text |
id | pubmed-5690227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56902272018-04-02 Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device Sumida, Iori Yamaguchi, Hajime Das, Indra J. Kizaki, Hisao Aboshi, Keiko Tsujii, Mari Yamada, Yuji Suzuki, Osamu Seo, Yuji Isohashi, Fumiaki Ogawa, Kazuhiko J Appl Clin Med Phys Radiation Oncology Physics Patient‐specific quality assurance for intensity‐modulated radiation therapy (IMRT) dose verification is essential. The aim of this study is to provide a new method based on the relative error distribution by comparing the fluence map from the treatment planning system (TPS) and the incident fluence deconvolved from the electronic portal imaging device (EPID) images. This method is validated for 10 head and neck IMRT cases. The fluence map of each beam was exported from the TPS and EPID images of the treatment beams were acquired. Measured EPID images were deconvolved to the incident fluence with proper corrections. The relative error distribution between the TPS fluence map and the incident fluence from the EPID was created. This was also created for a 2D diode array detector. The absolute point dose was measured with an ionization chamber, and the dose distribution was measured by a radiochromic film. In three cases, MLC leaf positions were intentionally changed to create the dose error as much as 5% against the planned dose and our fluence‐based method was tested using gamma index. Absolute errors between the predicted dose of 2D diode detector and of our method and measurements were [Formula: see text] and [Formula: see text] respectively. The gamma passing rate (3% global / 3 mm) of the TPS was higher than that of the 2D diode detector ([Formula: see text]), and lower than that of the EPID ([Formula: see text]). The gamma passing rate (2% global / 2 mm) of the TPS was higher than that of the 2D diode detector, while the gamma passing rate of the TPS was lower than that of EPID ([Formula: see text]). For three modified plans, the predicted dose errors against the measured dose were 1.10%, 2.14%, and [Formula: see text]. The predicted dose distributions from the EPID were well matched to the measurements. Our fluence‐based method provides very accurate dosimetry for IMRT patients. The method is simple and can be adapted to any clinic for complex cases. PACS numbers: 87.55.D‐, 87.55.km, 87.55.Qr, 87.57.uq John Wiley and Sons Inc. 2016-01-08 /pmc/articles/PMC5690227/ /pubmed/26894363 http://dx.doi.org/10.1120/jacmp.v17i1.5899 Text en © 2016 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Sumida, Iori Yamaguchi, Hajime Das, Indra J. Kizaki, Hisao Aboshi, Keiko Tsujii, Mari Yamada, Yuji Suzuki, Osamu Seo, Yuji Isohashi, Fumiaki Ogawa, Kazuhiko Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
title | Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
title_full | Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
title_fullStr | Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
title_full_unstemmed | Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
title_short | Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
title_sort | intensity‐modulated radiation therapy dose verification using fluence and portal imaging device |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690227/ https://www.ncbi.nlm.nih.gov/pubmed/26894363 http://dx.doi.org/10.1120/jacmp.v17i1.5899 |
work_keys_str_mv | AT sumidaiori intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT yamaguchihajime intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT dasindraj intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT kizakihisao intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT aboshikeiko intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT tsujiimari intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT yamadayuji intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT suzukiosamu intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT seoyuji intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT isohashifumiaki intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice AT ogawakazuhiko intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice |